Home Applications 219265 Application 219265
Type ANDA
Sponsor CARNEGIE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LOMUSTINE LOMUSTINE CAPSULE;ORAL 10MG No No 002 LOMUSTINE LOMUSTINE CAPSULE;ORAL 40MG No No 003 LOMUSTINE LOMUSTINE CAPSULE;ORAL 100MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A219265-001 LOMUSTINE LOMUSTINE 10MG CAPSULE / ORAL AB 2025-10-27 A219265-002 LOMUSTINE LOMUSTINE 40MG CAPSULE / ORAL AB 2025-10-27 A219265-003 LOMUSTINE LOMUSTINE 100MG CAPSULE / ORAL AB 2025-10-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration A219265-001 CGT 2026-05-19 A219265-002 CGT 2026-05-19 A219265-003 CGT 2026-05-19
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A219265-001 LOMUSTINE 10MG CAPSULE / ORAL AB 2025-10-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A219265-002 LOMUSTINE 40MG CAPSULE / ORAL AB 2025-10-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A219265-003 LOMUSTINE 100MG CAPSULE / ORAL AB 2025-10-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219265-001 LOMUSTINE 10MG CAPSULE / ORAL AB 2025-10-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219265-002 LOMUSTINE 40MG CAPSULE / ORAL AB 2025-10-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219265-003 LOMUSTINE 100MG CAPSULE / ORAL AB 2025-10-27 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219265-001 LOMUSTINE 10MG CAPSULE / ORAL AB 2025-10-27 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219265-002 LOMUSTINE 40MG CAPSULE / ORAL AB 2025-10-27 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219265-003 LOMUSTINE 100MG CAPSULE / ORAL AB 2025-10-27 a50c72e98297…
Observed Orange Book normalized TE history# Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219265-001 CGT 2026-05-19 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219265-002 CGT 2026-05-19 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219265-003 CGT 2026-05-19 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join LOMUSTINE LOMUSTINE Carnegie Pharmaceuticals LLC 916dfac8-da11-40e4-9e44-a909e29a6b5f 2025-10-28 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 219265 application number: ANDA219265